Trial intelligence / Profile preview

Metformin in COPD Exacerbations: Randomised Double-Blind Placebo-Controlled Pilot Study

2010-020818-28Phase 4Terminated

Sponsor
St George's, University of London
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Metformin with Placebo (2 arms). Primary endpoint: Mean capillary blood glucose concentration during hospitalisation. Started Oct 2010; status: terminated.

02

Drugs

metformin
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2010-020818-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020818-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call